Evidence map›Paper›PMID 29465988›Full record

ReviewBioconjugate chemistry2018

Light-Switchable Ion Channels and Receptors for Optogenetic Interrogation of Neuronal Signaling.

Wan-Chen Lin, Richard H Kramer

Abstract readReview
In one paragraph

Review in Bioconjugate chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Expanding the Genetic Code for Neuronal Studies.Chembiochem : a European journal of chemical biology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Wan-Chen LinDepartment of Molecular and Cell Biology , University of California, Berkeley , 121 Life Sciences Addition , Berkeley , California 94720 , United States.ORCID 0000-0001-7842-3036
Richard H KramerDepartment of Molecular and Cell Biology , University of California, Berkeley , 121 Life Sciences Addition , Berkeley , California 94720 , United States.

Funding

NDC for the Optical Control of Biological FunctionPN2EY018241 · NEI · UNIVERSITY OF CALIFORNIA BERKELEY · PI ISACOFF, EHUD · 2006 to 2015
$37.5M
UC Berkeley Vision Science COREP30EY003176 · NEI · UNIVERSITY OF CALIFORNIA BERKELEY · PI RICHARD H KRAMER · 1985 to 2026
$16.4M
Optical Control of Synaptic Transmission for in Vivo Analysis of Brain Circuits and BehaviorU01NS090527 · NINDS · UNIVERSITY OF CALIFORNIA BERKELEY · PI ISACOFF, EHUD, KRAMER, RICHARD H · 2014 to 2016
$2.4M
Probing GABAa receptor function and plasticity with lightR01NS100911 · NINDS · UNIVERSITY OF CALIFORNIA BERKELEY · PI KRAMER, RICHARD H · 2017 to 2020
$1.8M
NEI NIH HHS P30 EY003176NEI NIH HHS PN2 EY018241NINDS NIH HHS R01 NS100911NINDS NIH HHS U01 NS090527
6 · The paper itself

Abstract

Optogenetics is an emerging technique that enables precise and specific control of biological activities in defined space and time. This technique employs naturally occurring or engineered light-responsive proteins to manipulate the physiological processes of the target cells. To better elucidate the molecular bases of neural functions, substantial efforts have been made to confer light sensitivity onto ion channels and neurotransmitter receptors that mediate signaling events within and between neurons. The chemical strategies for engineering light-switchable channels/receptors and the neuronal implementation of these tools are discussed.

Indexed as

Signal TransductionAnimalsCysteineHumansIon ChannelsLightNeuronsOptogeneticsPhotochemical ProcessesProtein EngineeringReceptors, GABA-AReceptors, GlutamateReceptors, NeurotransmitterCysteineIon ChannelsReceptors, GABA-AReceptors, GlutamateReceptors, Neurotransmitter

Identifiers

PMID29465988
PMCPMC6456447

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.